NCT06358625View on ClinicalTrials.gov

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

June 6, 2031

Study Completion Date

June 6, 2031

Conditions
HER2-positive Breast Cancer
Interventions
OTHER

Pre-treatment biopsy

"A breast biopsy is performed just before the clip is placed in the tumour and additional blood samples are performed."

Trial Locations (1)

35 000

RECRUITING

Centre de lutte contre le cancer Eugène Marquis, Rennes

All Listed Sponsors
lead

Center Eugene Marquis

OTHER